WTBA vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

WTBA

61.4
AI Score
VS
CARE Wins

CARE

65.4
AI Score

Investment Advisor Scores

WTBA

61score
Recommendation
HOLD

CARE

65score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric WTBA CARE Winner
Forward P/E 13.2626 13.6612 WTBA
PEG Ratio 0 0 Tie
Revenue Growth 18.0% 68.3% CARE
Earnings Growth 36.2% 253.9% CARE
Tradestie Score 61.4/100 65.4/100 CARE
Profit Margin 37.1% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY CARE

Relative Price Performance (Last 90 Days)

WTBA 1M: -0.5% · 3M: +18.2% CARE 1M: -3.4% · 3M: +5.6%

Current Technical Phase

WTBA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 61

RSI (14): 61.0 · Price: $29.37

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.1 · Price: $31.23

Fundamentals Snapshot

Metric WTBA CARE
Market Cap
Forward P/E 10.4 12.0
Trailing P/E 13.0 5.4
Revenue (TTM)
Revenue Growth 0.2% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.5% 0.6%
EPS 2.25 5.84
Dividend Yield 0.03% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.